Business Heat Biologics stock more than doubles after ‘positive’ trial data of its lung cancer treatment News Desk February 9, 2021 Shares of Heat Biologics Inc. HTBX, +76.58% more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported “positive” interim data from …